Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry Study

Radiology 2026 Open access

Read full text
Authors: Johanne Ahrenfeldt, Jesper Huitfeld Jespersen, Pernille Tonnesen, Tommy Kjærgaard Nielsen, Anna Krarup Keller, Laura Iisager, Iben Lyskjær
DOI: 10.1148/radiol.251485
Cited by: 2
References: 27

Abstract

= .001), suggesting fewer complications with ablation. Conclusion In patients with T1a RCC, treatment with ablation demonstrated comparable progression risk but with fewer complications and shorter hospital stays. © The Author(s) 2026. Published by the Radiological Society of North America under a CC BY 4.0 license.

Fields of Study & Subjects

Renal cell carcinoma treatment Bladder and Urothelial Cancer Treatments Multiple and Secondary Primary Cancers

Publication details

Journal / source
Radiology
Publisher
Radiological Society of North America (RSNA)
Volume
318
Issue
3
Pages
e251485–e251485
Publication date
1 March 2026
Language
EN